Amended Securities Registration (section 12(b)) (8-a12b/a)
March 24 2017 - 7:14AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
W
ashington
,
D.C. 20549
FORM 8-A
Amendment No. 1
FOR REGISTRATION OF CERTAIN CLASSES OF
SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE
SECURITIES EXCHANGE ACT OF 1934
SINOVAC BIOTECH LTD.
(Exact name of registrant as specified
in its charter)
Antigua, West Indies
|
|
Not Applicable
|
(State or other jurisdiction
|
|
(I.R.S. Employer Identification
|
of incorporation or organization)
|
|
Number)
|
No. 39 Shangdi Xi Road,
Haidian District, Beijing 100085
People’s Republic of China
|
|
Not Applicable
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Securities to be registered pursuant to
Section 12(b) of the Act:
Title of each class
to be so registered
___________________________________
|
|
Name of each exchange on which each
class is to be registered
__________________________________
|
Preferred Share Purchase Rights
|
|
The NASDAQ Stock Market LLC
|
If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.
þ
If this form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.
¨
Securities Act registration statement file number to which this
form relates: Not applicable (if applicable)
Securities to be registered pursuant to Section 12(g) of the
Act: None.
Item 1. Description
of Registrant’s Securities to be Registered
Reference is hereby made to the Registration
Statement on Form 8-A filed by Sinovac Biotech Ltd., an Antigua and Barbuda company (the “Company”), with the Securities
and Exchange Commission (the “SEC”) on March 29, 2016 (the “Registration Statement”), relating to the Rights
Agreement, dated as of March 28, 2016 (the “Rights Agreement”) between the Company and Pacific Stock Transfer Company,
as Rights Agent. Such Registration Statement is hereby incorporated herein by reference.
On March 24, 2017, the Company entered into
an amendment to the Rights Agreement (the “Amendment”), to extend the expiration date of the rights contained therein
from March 27, 2017 to March 27, 2018.
The foregoing summary of the Amendment is
qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 4.1 to the Company’s
Form 6-K, filed with the SEC on March 24, 2017, and is incorporated herein by reference. A copy of the Rights Agreement and a summary
of its material terms were filed with the SEC on Form 6-K on March 29, 2016 (incorporated herein by reference by Exhibit 4.2).
Item 2. Exhibits
|
1.
|
Amendment to Rights Agreement, dated as of March 24, 2017, between Sinovac Biotech Ltd. and Pacific Stock Transfer Company,
as Rights Agent (incorporated by reference to Exhibit 4.1 of the Report on Form 6-K dated March 24, 2017 of Sinovac Biotech
Ltd.)
|
|
2.
|
Rights Agreement, dated as of March 28, 2016, between Sinovac Biotech Ltd. and Pacific Stock Transfer Company, as Rights Agent,
which includes the Form of Certificate of Designations of Series A Junior Participating Preferred Shares as Exhibit A, the Form
of Right Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Shares as Exhibit C (incorporated by reference
to Exhibit 4.1 of the Report on Form 6-K dated March 29, 2016 of Sinovac Biotech Ltd.)
|
|
3.
|
Press Release of Sinovac Biotech Ltd., dated March 24, 2017 (incorporated by reference to Exhibit 99.1 of the Report on Form
6-K dated March 24, 2017 of Sinovac Biotech Ltd.)
|
SIGNATURE
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.
|
SINOVAC BIOTECH LTD.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Nan Wang
|
|
|
|
|
Name: Nan Wang
|
|
|
|
|
Title: Chief Financial
Officer
|
|
Date: March 24, 2017
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From Sep 2023 to Sep 2024